Cargando…
Gambogic acid suppresses colon cancer cell activity in vitro
The aim of the present study was to elucidate the underlying mechanism of antitumor activity of gambogic acid (GA) in colon cancer. Human colon cancer SW620 cells were divided into five treatment groups, including no-treatment control (NC), low dose GA (10 µg/ml), medium dose GA (50 µg/ml), high dos...
Autores principales: | Zhou, Zailong, Ma, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755432/ https://www.ncbi.nlm.nih.gov/pubmed/31555380 http://dx.doi.org/10.3892/etm.2019.7912 |
Ejemplares similares
-
Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012) -
Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro
por: Chen, Jinhao, et al.
Publicado: (2015) -
Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis
por: Wang, Shujun, et al.
Publicado: (2023) -
Gambogic Acid Induces Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells by Suppressing Notch Signaling
por: Zhu, Minghua, et al.
Publicado: (2018) -
Gambogic acid suppresses cancer invasion and migration by inhibiting TGFβ1-induced epithelial-to-mesenchymal transition
por: Zhao, Kai, et al.
Publicado: (2017)